Status:
ENROLLING_BY_INVITATION
Serum Auto-Antibodies in Neurological Diseases
Lead Sponsor:
University of California, Davis
Conditions:
Multiple Sclerosis
Myasthenia Gravis
Eligibility:
All Genders
18+ years
Brief Summary
Under normal conditions our immune system protects us against infections and tumors. The immune system does this by recognizing that the infecting organism or the tumor is foreign to the body and atta...
Detailed Description
The purposes of the study are to determine the frequency of auto-antibodies to 1) heat shock proteins and 2) to other molecules including cytoskeletal proteins such as rapsyn in diseases of the nervou...
Eligibility Criteria
Inclusion
- 18 years or older
- Diagnosis of multiple sclerosis, myasthenia gravis, or other autoimmune or inflammatory neurological disease
Exclusion
- inability to give informed consent
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2031
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00704626
Start Date
January 1 2002
End Date
March 1 2031
Last Update
May 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, Davis
Sacramento, California, United States, 95817